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abstract
 
Substance
 
 P 
 
and other polycationic peptides are thought to stimulate mast cell degranulation via di-
rect activation of G proteins. We investigated the ability of extracellularly applied substance
 
 P 
 
to translocate into
mast cells and the ability of intracellularly applied substance
 
 P 
 
to stimulate degranulation. In addition, we studied
by reverse transcriptionÐ-PCR whether substance
 
 P-
 
specific receptors are present in the mast cell membrane. To
study translocation, a biologically active and enzymatically stable fluorescent analogue of substance
 
 P 
 
was synthe-
sized. A rapid, substance
 
 P 
 
receptor- and energy-independent uptake of this peptide into pertussis toxin-treated
and -untreated mast cells was demonstrated using confocal laser scanning microscopy. The peptide was shown to
localize preferentially on or inside the mast cell granules using electron microscopic autoradiography with 
 
125
 
I-
labeled all-D substance
 
 P 
 
and 
 
3
 
H-labeled substance 
 
P
 
. Cell membrane capacitance measurements using the patch-
clamp technique demonstrated that intracellularly applied substance
 
 P 
 
induced calcium transients and activated
mast cell exocytosis with a time delay that depended on peptide concentration (delay of 100Ð500 s at concentra-
tions of substance
 
 P 
 
from 50 to 5 
 
m
 
M). Degranulation in response to intracellularly applied substance 
 
P
 
 was inhib-
ited by GDP
 
b
 
S and pertussis toxin, suggesting that substance
 
 P
 
 acts via G protein activation. These results support
the recently proposed model of a receptor-independent mechanism of peptide-induced mast cell degranulation,
which assumes a direct interaction of peptides with G protein 
 
a
 
 subunits subsequent to their translocation across
the plasma membrane.
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introduction
 
Mast cells stimulated with immunoglobulin E/antigen
release a variety of preformed mediators (e.g., hista-
mine) by exocytosis. They can, however, also be trig-
gered to undergo exocytosis by nonantigenic stimuli.
Polycationic substances, such as the neuropeptides sub-
stance
 
 P 
 
(SP)
 
1 
 
(Repke and Bienert, 1987) or neuropep-
tide Y (Gundemar and Hkanson, 1991), or the venom
peptides mastoparan and mast cell degranulating pep-
tide (Mousli et al., 1989; Landry et al., 1992), and natu-
rally occurring or synthetic polyamines such as sper-
mine (Purcell et al., 1996) and compound 48/80 (Pa-
ton, 1951) stimulate the release of vasoactive and
inflammatory compounds from mast cells. The peptid-
ergic stimulation of mast cells has raised the question
of whether other peptide-secreting cells in the vicinity
of mast cells are capable of stimulating mast cells. In
this context, it is interesting to note that mast cells have
been found in close proximity to peptidergic neurones,
suggesting a probable functional relationship between
the immune and nervous systems (McKay and Bienen-
stock, 1994; Marshall and Waserman, 1995; Purcell and
Atterwill, 1995) mediated by neuropeptides.
The mechanism by which cationic peptides and
polyamines stimulate mast cell exocytosis remains un-
clear. It is generally accepted that heterotrimeric GTP-
binding proteins (G proteins) are involved in the stim-
ulation of mast cell degranulation by basic secretagogues.
Thus, application of substance
 
 P 
 
and other cationic
secretagogues transiently increases intracellular Ca
 
2
 
1
 
concentrations through G protein-mediated activation
of phospholipase C (PLC), and pretreatment of mast
cells with pertussis toxin abolishes both inositol-3-phos-
phate production and peptide-induced mast cell de-
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Abbreviations used in this paper:
 
 
 
3
 
H-SP, 
 
3
 
H-labeled SP; all-D-SP,
D-amino acid analogue of SP; CLSM, confocal laser scanning micros-
copy; C
 
m
 
, membrane capacitance; ES, external bath solution; FLUOS-
SP, 5(6)-carboxyfluorescein-labeled Arg
 
3
 
,Orn
 
7
 
-SP; FLUOS-all-D-SP,
5(6)-carboxyfluorescein-labeled all-D-Arg
 
3
 
,Orn
 
7
 
-SP; GAPDH, glycer-
aldehyde-phosphate dehydrogenase; IS, intracellular or pipette solu-
tion; PLC, phospholipase C; PtX, pertussis toxin; ROI, region of in-
terest; R
 
s
 
, series resistance; RT-PCR, reverse transcriptionÐPCR; SP,
substance 
 
P
 
.
  
578
 
Peptide-induced Mast Cell Degranulation
 
granulation (Mousli et al., 1989, 1995; Emadi-Khiav et
al., 1995). Experiments with permeabilized (Cockcroft
et al., 1987; Aridor et al., 1990; Lillie and Gomperts,
1992) and patch-clamped (Lindau and N§e, 1987;
Penner, 1988) mast cells and neutrophils (N§e and
Lindau, 1990) have demonstrated the involvement of a
G protein downstream of PLC capable of inducing exo-
cytosis. A recently identified heterotrimeric G protein
(G
 
i3
 
) on the plasma membrane of mast cells (Aridor et
al., 1993) is thought to participate in the control of one
of the late steps of exocytosis. Furthermore, cationic
peptides stimulate purified and reconstituted G
 
i
 
/G
 
o
 
proteins from calf brain (Higashijima et al., 1990; Mou-
sli et al., 1990
 
a
 
, 1995) and G proteins from rat perito-
neal mast cells (Bueb et al., 1990; Fischer et al., 1993).
However, the presence of specific peptide receptors in
the mast cell membrane is questionable. Peptide con-
centrations in the micromolar range are necessary to
induce mast cell degranulation and both studies of
structureÐactivity relationships and receptor autorad-
iography failed to detect specific peptide receptors on
mast cells (Repke and Bienert, 1987; Repke et al., 1987;
OÕFlynn et al., 1989; Mousli et al., 1994). In view of
these difficulties, Mousli et al. (1990
 
b
 
) proposed a di-
rect interaction of cationic peptides with heterotri-
meric G proteins without the participation of a recep-
tor. This process would require insertion into and
translocation of peptides across the plasma membrane.
In previous studies it was also proposed that the initial
event in peptide-induced mast cell stimulation might
be an interaction of the cationic peptides with nega-
tively charged sites (e.g., sialic acid containing glyco-
proteins) at the mast cell membrane (Mousli et al.,
1990
 
b
 
, Emadi-Khiav et al., 1995). In contrast to the re-
quirements for the activation of purified G
 
i
 
 proteins by
mastoparan-peptides, amphipathic helicity was pro-
posed to be not obligatory for peptide-induced mast
cell activation (Cross et al., 1995). Nevertheless, these
investigations do not exclude the possibility of a direct
interaction of exogenous peptides with G proteins after
their binding to glycoproteins and subsequent trans-
port across the plasma membrane into the cell.
The aim of the present investigation was to clarify
whether a transport of cationic peptides into rat perito-
neal mast cells is possible and whether intracellularly
applied peptide can induce mast cell degranulation.
The transport studies were performed by confocal laser
scanning microscopy using fluorescence-labeled Arg
 
3
 
,
Orn
 
7
 
-SP (FLUOS-SP) and its D-amino acid analogue,
all-D-Arg
 
3
 
,Orn
 
7
 
-SP (FLUOS-all-D-SP), as well as by elec-
tron microscopic autoradiography using 
 
3
 
H-labeled SP
and 
 
125
 
I-labeled all-D-SP. The action of intracellularly
applied peptide on mast cell degranulation was studied
by cell membrane capacitance measurements using the
patch-clamp technique in the whole-cell configuration.
Additionally, in search of SP-specific receptors in rat
peritoneal mast cells, reverse transcriptionÐPCR (RT-
PCR) was used.
The results of our investigations demonstrate that SP
peptides can be rapidly and energy-independently
translocated into mast cells. By electron microscopic
studies, an exclusively granule-related intracellular lo-
cation of SP was confirmed. Moreover, intracellularly
applied peptide was shown to induce mast cell activa-
tion. In addition, SP receptor-specific mRNA was not
detected. These results support the concept of a recep-
tor-independent but receptor-mimicking action of SP
when mast cells are exposed to micromolar concentra-
tions of SP in vitro.
 
materials and methods
 
Reagents
 
Unless otherwise noted, all reagents and chemicals were pur-
chased from Sigma Chemical Co. (Deisenhofen, Germany).
 
Peptide Synthesis and Fluorescence Labeling of Peptides 
 
Substance
 
 P 
 
(H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-MetNH
 
2
 
)
and its D-amino acid analogue all-D-SP were synthesized by solid-
phase method using standard Fmoc chemistry and purified (pu-
rity 
 
. 
 
95%) as described (Cross et al., 1995). For fluorescence label-
ing, 5.6 
 
m
 
mol H-Arg-Pro-Arg-Pro-Gln-Gln-Phe-Orn-Gly-Leu-MetNH
 
2
 
(Arg
 
3
 
,Orn
 
7
 
-SP) or the corresponding all-D-peptide, respectively,
were dissolved in 3.3 ml 0.1 M borate buffer (pH 9.0) and 4.7 
 
m
 
mol
5(6)-carboxyfluorescein-
 
N
 
9
 
-hydroxysuccinimide ester (FLUOS;
Boehringer Mannheim, Mannheim, Germany) dissolved in 0.8
ml acetonitrile was added. The reaction mixture was incubated at
25
 
8
 
C for 15 min in the dark. Under these conditions, the labeling
occurs selectively at the 
 
N
 
e
 
-amino group of Orn. The FLUOS pep-
tides were purified by semipreparative HPLC (purity 
 
. 
 
95%).
 
Mast Cell Preparation
 
Peritoneal mast cells were obtained from male Wistar rats (300Ð
350 g) by peritoneal lavage with incubation medium containing
(mM): 112 NaCl, 4 KCl, 1 MgCl
 
2
 
, 1.6 CaCl
 
2
 
, 8 HEPES, 6.7 glu-
cose, 36 NaHCO
 
3
 
, 0.32 KH
 
2
 
PO
 
4
 
, 2.2 HCl, pH 7.3, 300 mOsm/kg.
After centrifugation (150 
 
g
 
, 5 min) and resuspension of the pel-
let in 2 ml HEPES buffer containing (mM): 135 NaCl, 2.7 KCl,
1.8 CaCl
 
2
 
, 1 MgCl
 
2
 
, 20 HEPES, 5.6 glucose, 1 mg/ml bovine se-
rum albumin, pH 7.3, 300 mOsm/kg, cells were purified by cen-
trifugation through 2 ml isotonic Percoll (Pharmacia Fine Chem-
icals, Uppsala, Sweden) (75%) at 200 
 
g
 
 for 15 min, washed and
centrifuged twice at 100 
 
g
 
 for 5 min in HEPES buffer. Cells were
subsequently resuspended either in external solution (ES) (con-
taining [mM]: 140 NaCl, 5 KCl, 2 CaCl
 
2
 
, 1 MgCl
 
2
 
, 10 HEPES, 15
glucose, pH 7.2, 300 mOsm/kg) for transport experiments or in
DulbeccoÕs modified Eagle medium (nutrient mixture F-12
HAM) supplemented with 2 mM glutamine and incubated in a
humidified atmosphere with 5% CO
 
2
 
 and 95% air at 37
 
8
 
C before
use in patch-clamp experiments. The cell purity and viability
were tested by toluidine blue staining and trypan blue exclusion
(both 
 
. 
 
95%), respectively. 
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Pertussis Toxin Treatment
 
To prevent degranulation during the transport experiments and
in some patch-clamp experiments, mast cells were pretreated
with 200 ng/ml pertussis toxin (PtX) for 2 h or with 1 
 
m
 
g/ml for
up to 9 h, respectively, at 37
 
8
 
C in a humidified atmosphere with
5% CO
 
2
 
 and 95% air.
 
Histamine Release
 
Histamine release was quantified as described previously (Cross
et al., 1993). In brief, an aliquot of rat peritoneal mast cells in ES
was incubated with an aliquot of peptide solution for 10 min at
37
 
8
 
C. The reaction was quenched by adding ice cold ES, the sus-
pension was centrifuged at 200 
 
g
 
 for 5 min and the supernatant
removed for histamine assay. The total amount of histamine was
determined from control samples after incubation in a boiling
water bath for 5 min. The histamine assay was performed as de-
scribed by Repke et al. (1987).
Release was expressed as a percentage of the total histamine
content of the cells and was corrected for the spontaneous re-
lease occurring in the absence of any stimuli.
 
Translocation Experiments
 
Confocal laser scanning microscopy.
 
For the investigation of translo-
cation of SP across the plasma membrane into the cytoplasm of
mast cells, FLUOS-SP and FLUOS-all-D-SP were used. The reason
for using the D-amino acid analogue of SP is its resistance to en-
zymatic degradation compared with SP. High performance liquid
chromatographic studies showed that SP was degraded in mast
cell suspension and in supernatants of mast cell suspensions
within 30 min of incubation, whereas all-D-SP was not degraded
even after 1 h of incubation (D. Lorenz, unpublished results). To
prevent degranulation-induced artifacts during the transport ex-
periments, mast cells were pretreated with PtX.
Three series of experiments were performed.
(
 
a
 
) Purified PtX-treated mast cells were incubated with 30 
 
m
 
M
peptide solution in ES for 1Ð32 min at room temperature and
washed three times (centrifugation at 100 
 
g
 
, 20 min) in 9 ml ice
cold ES supplemented with 6 mM CaCl
 
2
 
 and 1% bovine serum al-
bumin to remove extracellular peptide. The cell pellets were re-
suspended in 200 
 
m
 
l ES and allowed to adhere to the glass base of
a culture dish. The intracellular fluorescence intensity from the
central optical section of single mast cells was then monitored.
(
 
b
 
) 200 
 
m
 
l of a 2.5-
 
m
 
M peptide solution were added via a 1-ml
syringe to 200 
 
m
 
l of ES in a dish containing adherent mast cells.
The time courses of the fluorescence intensities inside and out-
side the cell in predetermined regions of interest (ROIs, 16 
 
3 
 
16
pixel) were simultaneously recorded at a frequency of 0.2 Hz for
up to 30 min. The background fluorescence intensity was deter-
mined before the addition of the peptide solution for 300 s. Due
to the strong extracellular fluorescence intensity, the intracellu-
lar signal was superimposed to some extent by extracellular fluo-
rescence arising from the nonideal confocal properties of the
confocal laser scanning microscopy (CLSM). The intracellular
fluorescence signal was corrected for this contribution by esti-
mating the distribution function of the sensitivity in the z direc-
tion of the microscope, as described elsewhere (Wiesner, Lorenz,
Krause, Baeger, Beyermann, and Bienert, manuscript in prepara-
tion).
(
 
c
 
) 100 
 
m
 
l of solutions containing different peptide concentra-
tions were mixed with 100 
 
m
 
l of mast cell suspension 5 min be-
fore measurements. The cells were allowed to adhere and the flu-
orescence intensities of ROIs inside and outside the cell were
measured (30 scans with a scan time of 2 s with double averag-
ing). All intensities were corrected for the small contribution
from extracellular out-of-focus-fluorescence as described. For
measurements with metabolically inhibited cells, the cells in ES
without glucose were treated with 1 
 
m
 
M antimycin for 20 min at
37
 
8
 
C or with 33 
 
m
 
M dinitrophenol for 10 min at room tempera-
ture before the addition of the peptide solution. Additionally, an-
timycin was added simultaneously with the peptide solution and
the suspensions were subsequently incubated for the given times.
After each measurement, 100 
 
m
 
l of 0.5% trypan blue were
added to the cells and the trypan blue fluorescence (
 
l
 
exc
 
 5 
 
543
nm, 
 
l
 
em 
 
. 
 
590 nm) was monitored to confirm the integrity of
the plasma membrane. 
For all translocation studies, we used the confocal laser scan-
ning microscope LSM 410 Invert (Carl Zeiss Jena GmbH, Jena,
Germany) with an excitation Argon-Krypton laser (488 nm) and
a Helium-Neon laser (543 nm). The laser beam was focused with
a 
 
3
 
63/1.25 oil immersion objective (Plan-Neofluar; Carl Zeiss
Jena GmbH). The fluorescence light passed through a dichroic
mirror (FT 510 at excitation 488 nm, NT 543/80/20 at excitation
543 nm, both from Carl Zeiss Jena GmbH) and an additional cut-
off-filter (LP 515 at excitation 488 nm and LP 590 at excitation
543 nm, both from Carl Zeiss Jena GmbH) in front of the photo-
multiplier.
The data were expressed as mean 
 
6 
 
SD.
 
Electron Microscopic Autoradiography
 
For these experiments, 
 
3
 
H-labeled SP (
 
3
 
H-SP) ([2-prolyl-3,4-
 
3
 
H(N)]-SP, specific activity 1,147 GBq/mmol, 37 MBq/ml; Du-
Pont/NEN, Bad Homburg, Germany) and 
 
125
 
I-labeled all-D-SP
(
 
125
 
I-all-D-SP) (
 
125
 
I labeling of all-D-SP on Lys via the Bulton-
Hunter reaction by [DuPont/NEN]: specific activity 81,400
GBq/mmol, 7.4 MBq/ml) were used. The radio-chemical purity
was determined before the experiments by radioactive HPLC and
was found to be 98.4 and 95.6% for 
 
3
 
H-SP and 
 
125
 
I-all-D-SP, re-
spectively (HPLC-system; JASCO, Tokyo, Japan, radioactivity
HPLC-monitor RAMONA 93; RAYTEST, Straubenhardt, Ger-
many, HPLC column (250 3 4 mm), and precolumn LiChros-
pher 100 RP-18, 5 mm endcapped; Merck, Darmstadt, Germany,
mobile phase: 30% acetonitrile/70% aqueous-0.2% trifluoroace-
tic acid).
Pooled, purified, PtX-treated, and washed, cells were incu-
bated for 10 min at room temperature with 1.5 ml 3H-SP solution
in ES (1.8 MBq; final volume of cell suspension, 1.6 ml; peptide
concentration, 1 mM) and for 10 and 60 min with 1.0 ml 125I-all-
D-SP solution (0.18 MBq; final volume of cell suspension, 1.1 ml;
peptide concentration, 2 nM). In control experiments, cells were
incubated with SP or all-D-SP solutions with the same concentra-
tion of unlabeled peptide. After centrifugation (200 g, 2 min)
and washing twice with ES and subsequently with phosphate
buffer (0.1 M, pH 7.4, 290 mOsm/kg), the resuspended cells
were fixed in phosphate-buffered 3% glutaraldehyde with contin-
uous shaking for 1 h at room temperature. Post-fixation with os-
mium tetroxide was omitted to prevent dislocation and/or loss of
SP cross-linked with cellular proteins by glutaraldehyde. After care-
ful rinses (six times) with phosphate buffer, mast cells were sol-
idly pelleted in the presence of low gel point agarose (2%). These
tissue-like specimens were, after microdissection, dehydrated by
graded concentrations of ethanol, embedded in Epon 812, and
sectioned with an Ultracut S (REICHERT, Vienna, Austria).
The ultrathin sections were coated with monocrystalline layers
of ILFORD Nuclear Research Emulsion L 4 (ILFORD PHOTO
Co., London, UK). After exposure for 12 wk (48C), autoradio-
graphs were developed (KODAK D 19; Eastman Kodak Co.,
Rochester, NY) and investigated using a ZEISS 902 A electron mi-
croscope (Carl Zeiss Jena GmbH) at 80 kV.580 Peptide-induced Mast Cell Degranulation
In addition to electron microscopic autoradiography, the up-
take of SP was also examined autoradiographically on native mast
cells. For this purpose, PtX- and SP-treated washed (once ES,
once phosphate buffer) cells were resuspended in a small volume
of phosphate-buffered 20% polyvinylpyrrolidone (K30) solution
(as cryoprotectant) and transferred into channels (2 mm diame-
ter, 4 mm deep) punched into slices of unfixed liver tissue. These
specimens were shock frozen on an aluminium block (80 mm di-
ameter, 250 mm high) and placed in liquid nitrogen. After stor-
age at 2808C for some days, the mast cells ÒembeddedÓ in liver
tissue were sectioned (5 mm) with a cryostat (LEICA/Jung CM
3000; Leica Inc., Deerfield, IL), mounted on poly-l-lysine coated
slides, air dried, and dipped in ILFORD nuclear Research Emul-
sion L 4 (diluted 1:1). Exposure at 48C with desiccant for 4 wk
was followed by development of autoradiographs with KODAK D
19 (1:1), staining with neutral red and investigation using a LEITZ
microscope DIAPLAN (Leica Mikroskopie und Systeme GmbH,
Wetzlar, Germany).
Patch-Clamp Measurements
The action of intracellularly applied SP on degranulation was
monitored by measurements of cell membrane capacitance using
the patch-clamp technique. Experiments were performed in a
tight seal whole-cell voltage-clamp at room temperature. Data
were collected with an EPC-9 amplifier (HEKA elektronik, Lam-
brecht, Germany) using HEKA-software PULSE and X-CHART
run on a Macintosh Quadra 650 computer. Membrane capaci-
tance (Cm) and series resistance (Rs) were measured automati-
cally by the EPC-9 Òcap.trackÓ feature, based on the Òtime do-
mainÓ technique (Lindau and Neher, 1988) and the use of an al-
gorithm described by Sigworth et al. (1995). This technique has
been shown to produce equivalent values of Cm to those obtained
with the Òfrequency domainÓ method (Neher and Zucker, 1993).
The filters were set by the software automatically; the amplitude
of the square-wave voltage pulses was set to 5 mV, and 15 cycles
were used for Cm and Rs estimates. The frequency for Cm and Rs
determination was 3Ð4 Hz. Membrane resistance (Rm) was ob-
tained by subtracting Rs from the quantity Rm displayed in the
EPC-9 window. Holding potential was set to 0 mV. No corrections
were made for liquid junction potential, which was determined
to be 8.3 mV for the bath and pipette solution used. In parallel
with capacitance measurements, the degranulation was moni-
tored by a video camera mounted on the microscope (ZEISS AX-
IOVERT TV 135; Carl Zeiss Jena GmbH) equipped with Nomar-
ski optics.
Sylgard-coated borosilicate glass pipettes (Hilgenberg, Malsfeld,
Germany) were used (electrode resistance 2.5Ð5 MV when filled
with the intracellular pipette solution). In the experiments with
dialyzed peptide, Rs varied between 10 and 80 MV and membrane
conductance (Gm) between 0.2 and 5 nS. For evaluation of the
data, only cells with Rs , 50 MV and Gm , 2 nS were considered.
Bath solution ES contained (mM): 140 NaCl, 5 KCl, 2 CaCl2,
1 MgCl2, 10 HEPES, 15Ð20 mM glucose, pH 7.2, 300 mOsm/kg).
Pipette solution (IS) 1 contained (mM): 135 K-glutamate, 10
NaCl, 7 MgCl2, 10 HEPES, 0.5 MgATP, pH 7.2, 290 mOsm/kg.
EGTA, GTPgS (Boehringer Mannheim), and SP were added at
the desired concentration as indicated in the figures. IS 2 was of
the same composition as IS 1 but with 20 mM NaCl and 1 mM
MgCl2.
Degranulation measured as increase of capacitance in patch-
clamped mast cells started after a delay after patch rupture and
peptide diffusion into the cell. Thereafter, the degranulation
proceeded for several minutes and the capacitance approached a
final value. For comparison of different cells, the time delay was
defined as that time at which the capacitance increased by 10%
of the initial value; the rate of degranulation was obtained from
the average slope of the curve between 10 and 90% of the de-
granulation amplitude.
Measurement of diffusion of the peptide from the pipette into
the cell using FLUOS-all-D-SP was performed using previously de-
scribed equipment for patch-clamp and fluorescence measure-
ments (N§e and Lindau, 1990) and also using the Ca21-imaging
IONVISION system (Improvision, Coventry, UK) coupled to the
patch-clamp set-up using an extended ISIS Intensified CCD-cam-
era (Photonics Science, Millham, UK), the polychromatic illumi-
nation system (TILL photonics, Munich, Germany) at excitation
wavelength 488 nm, FLUAR 3100/1.3 oil immersion objective
(Carl Zeiss Jena GmbH) and dichroic mirror FT 510, as well as a
cut-off filter LP 520 (both Carl Zeiss Jena GmbH) in the AXIO-
VERT TV135 microscope and the IONVISION software.
Intracellular free Ca21 concentrations [Ca21]i in patch-clamped
mast cells were determined in parallel with Cm measurements
with 100 mM FURA-2 (Molecular Probes, Inc., Eugene, OR)
loaded into the cells by diffusion from the recording pipette.
Fluorescence images (using a dichroic mirror Zeiss FT 425 and
an interference filter Zeiss IF 500Ð530 in front of the CCD
camera) were captured by alternately exciting FURA-2 in the
cells at 340 nm (image A) and 380 nm (image B). Background
images were captured in the cell-attached configuration before
patch rupture. After background subtraction, the ratioing of the
images (A/B) was performed off-line and converted on a pixel by
pixel basis to an image that represented the variable ion concen-
tration within the cell. For calibration of the system, mast cells
were patched with IS 2 containing 100 mM FURA-2 and Ca21
buffers with known concentrations of free Ca21 (10 mM EGTA
supplemented to the appropriate CaCl2 concentrations prepared
using the concentrated Ca21 buffering kit from Molecular
Probes, Inc.), and the fluorescence images from 340 and 380 nm
excitation were recorded. The ratio of fluorescence intensity
(grey levels) inside the cell at the two excitation wavelengths was
calculated after background subtraction from the two images. Us-
ing IONVISION software, a calibration curve (ratio versus
[Ca21]i) was derived and used for the determination of free Ca21
concentration inside the cell. Images were captured by averaging
two frames. Dual image acquisition was performed every 1.66 s.
The data from patch-clamp measurements were expressed as
mean 6 SEM (number of cells).
PCR Experiments
Total RNA was isolated from purified peritoneal rat mast cells
and rat pituitary cells (as positive control) as previously described
(Chomczynski and Sacchi, 1987). The total RNA from mast cells
was treated with heparinase I according to Oberhauser et al.
(1994) to remove native mast cell heparin, which disturbs the PCR.
The oligonucleotide primers for the substance P receptor PCR
were purchased from MWG Biotech (Ebersberg, Germany).
Primers were designed from the published cDNA sequences of
rat NK1 receptor and the rat glyceraldehyde-phosphate dehy-
drogenase (GAPDH). The sequences of the rat NK1 receptor
primers corresponds to bases 1371Ð1391 (sense) and 1735Ð1755
(antisense) of this receptor gene (Yokota et al., 1989). The se-
quence of the 59-end digoxigenin-labeled oligonucleotide corre-
sponds to bases 1629Ð1674 in the above mentioned NK1 receptor
sequence. The sequences of the rat GAPDH primers correspond
to bases 478Ð497 (sense) and 798Ð817 (antisense) of this gene
(Tso et al., 1985).
The Gene Amp RNA-PCR kit (Perkin-Elmer Corp., Beacons-
field, UK) was used for RT-PCR. Each sample, containing 0.5Ð1
mg of total cellular RNA, was reverse transcribed according to the
manufacturerÕs protocol in the presence of oligo d(T)16, and581 Lorenz et al.
then amplified. The amplification protocol for the rat NK1 recep-
tor primers was as follows: an initial 2-min cycle at 958C, followed
by 35 cycles of denaturation at 948C for 1 min, primer annealing
at 518C for 30 s, and extension at 728C for 45 s at the first cycle
with an extension time of 2 s per cycle. After the last cycle, an ex-
tension of 7 min at 728C was carried out. The amplification pro-
tocol for the rat GAPDH primers was: an initial 2-min cycle at
958C, followed by 30 cycles of denaturation at 948C for 45 s,
primer annealing at 578C for 45 s, and extension at 728C for 45 s
at the first cycle with an extension time of 1 s per cycle. After the
last cycle, an extension of 7 min at 728C was carried out. After RT-
PCR, 5 ml from the 50-ml reaction mixture was electrophoresed
through a 3% NuSieve agarose gel buffered with TAE (40 mM
Tris-acetate, 2 mM EDTA). The gel was stained with ethidium
bromide. Southern hybridization of NK1 receptor PCR products
was carried out as described previously (Winkler et al., 1995).
The PCR product obtained by use of GAPDH-specific primers
was cloned into the Bluescript II KS(1) plasmid and sequenced
(ABI 373 system; Perkin-Elmer Cetus) with a T7 standard primer
to confirm the PCR product obtained as being identical to the
published cDNA sequence.
results
Translocation of SP into Mast CellsÑCLSM and Electron 
Microscopic Autoradiography 
To investigate the uptake of SP into mast cells by
CLSM, fluorescein-labeled SP derivatives were synthe-
sized. These SP analogues showed mast cell degranulat-
ing activities comparable with SP with ED25 (concentra-
tion required for 25% histamine release) of 15 6 2.3,
29  6  4.6, and 62 6 4.1 mM for SP, all-D-SP, and
FLUOS-all-D-SP, respectively. The ED25 for SP is higher
than the reported value (Cross et al., 1995), probably
due to the higher extracellular CaCl2 concentration
used in our experiments. A competition between Ca21
and SP peptides for negatively charged binding sites on
the mast cell membrane may be responsible for the ob-
served higher value of ED25 for SP at the used higher
Ca21 concentration (Mousli et al., 1989). For transloca-
tion experiments, mast cells were pretreated with per-
tussis toxin to prevent degranulation artifacts.
Fig. 1 shows mast cells after incubation for 1 min in
30  mM FLUOS-all-D-SP solution and after multiple
washes. An intracellular fluorescence signal is clearly
visible. This signal corresponds to the intact peptide be-
cause FLUOS-all-D-SP is not degraded by mast cell pro-
teases (D. Lorenz, unpublished results). Prolongation
of the incubation time up to 32 min did not increase
the fluorescence signal inside the cell, indicating that
the uptake was rapid.
A more detailed insight in the kinetics of peptide up-
take was obtained by experiments where the fluores-
cence increase was monitored in real time (Fig. 2). In
these experiments, a solution containing FLUOS-all-D-
SP was added via syringe and the time course of the flu-
orescence increase was simultaneously measured in the
bath and inside the cells (Fig. 2, B and C). The intracel-
lular fluorescence increased in parallel with growing
extracellular fluorescence. The time to attain the fluo-
rescence maximum varied only slightly, by 6 6 4 s (n 5 3),
compared with that of extracellular fluorescence and
the half-rise time, which changed by 20 6 13 s (n 5 3).
After establishment of a constant value of external
fluorescence intensity, z10% of the extracellular fluo-
rescence intensity was found intracellularly. This frac-
tion was independent of the used concentration of
FLUOS-all-D-SP in the range of 0.9Ð8 mM, and did not
change if increasing concentrations of unlabeled all-D-
SP up to 200 mM were added (Fig. 3), indicating that
the process was not saturable. Similar results were ob-
tained when PtX-treated mast cells were incubated first
with the unlabeled peptide, and then with the labeled
peptide. Furthermore, no change in the peptide up-
take was found when the cells were metabolically inhib-
ited by antimycin or dinitrophenol (15 6 2, 17 6 3,
and 18 6 3% uptake with antimycin, dinitrophenol,
and without metabolic inhibitors, respectively).
Figure  1. Intracellular uptake
of peptide into mast cells. PtX-
treated mast cells in ES were in-
cubated for 1 min with 30 mM
FLUOS-all-D-SP and subse-
quently washed with ES (supple-
mented with 6 mM CaCl2 and 1
mg/ml bovine serum albumin).
(left) Transmission image, (right)
fluorescence image. Control cells
without SP showed no fluores-
cence signal when monitored
with the same settings of the con-
focal microscope as before. The
scan area was adjusted to the cen-
ter of mast cells.582 Peptide-induced Mast Cell Degranulation
Eq. 1 describes the expected time course of the intracel-
lular fluorescence intensity Icell(t), assuming (a) a simple
diffusion of the peptide through the plasma membrane
into the cell according to the first FickÕs law, and (b) a
direct proportional relation between fluorescence in-
tensity and peptide concentration considering the pep-
tide concentration as homogeneous within the cell.
(1)
with k1 5 k2 5 k, k 5 rate constant of diffusion, and I(z)
is the measured extracellular fluorescence intensity.
No value for k was found that could give an adequate
description of the experimentally observed time course
Icell(t). A better fit of the experimental data to Eq. 1 was
obtained when different values of k1 and k2 (k1 5 0.1
s21; k2 5 0.5 s21) were used (Fig. 2 D). Nevertheless, the
values of the plateau of Icell(t) were found to be lower
than the values predicted by Eq. 1 for all combinations
of k1 and k2. This fact points to the involvement of a sec-
ond process in the peptide translocation at later times,
for instance a transport into a second pool inside the
cell, such as a transport from the cytoplasm into the
granules or other intracellular compartments. This
case should be described by Eq. 2: 
Icell t () k1 I
t0
t
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Figure 3. Independence of the fraction of translocated FLUOS-
all-D-SP on the extracellular peptide concentration. PtX-treated
mast cells were incubated for 5 min with the indicated concentra-
tions of FLUOS-all-D-SP (d), or with 6.6 mM FLUOS-all-D-SP plus
the indicated concentrations of unlabeled all-D-SP (h), and the
fluorescence intensity inside and outside the cell was measured.
The fraction of translocated FLUOS-all-D-SP is shown as intracellu-
lar fluorescence intensity (after background correction) normal-
ized to the extracellular fluorescence intensity.
Figure 2. Kinetics of uptake of FLUOS-all-D-SP from extracellu-
lar medium into PtX-treated mast cells and fit of experimental
data to a diffusion model. 200 ml of FLUOS-all-D-SP solution (2.5
mM) were applied via a syringe to 200 ml of ES in a dish containing
mast cells adhered to the glass base of the dish. The fluorescence
intensities inside and outside the cell were measured. (A, left) The
transmission image of a mast cell before application of peptide
and location of ROIs (16 3 16 pixels or 1.4 3 1.4 mm) in the scan
area in the bath and inside the cell. (middle) The fluorescence im-
age of the same mast cell before application of peptide. (right) The
fluorescence image of the same cell after application of FLUOS-all-
D-SP at time of maximal fluorescence intensity. (B) Mean fluores-
cence intensity inside and outside the cell from four ROIs, normal-
ized to the highest value of extracellular fluorescence intensity; the
arrow indicates the time of application of the peptide. (C) Mean
fluorescence intensities inside and outside the cell normalized to
their highest values. (D) Mean fluorescence intensity inside the
cell as in B and the best fit of the data to Eq. 1 with k1 5 0.1 s21;
k2 5 0.5 s21. The fitting was performed using IDL software (RSI,
Boulder, CO).583 Lorenz et al.
Figure 4. Intracellular location
of translocated 125I-all-D-SP in
mast cells. Electron microscopic
autoradiographs were obtained
from PtX-treated mast cells incu-
bated with 125I-all-D-SP for 10
min and subsequently washed.
AÐE demonstrate, representa-
tively for all investigated cells,
that silver grains resulting from
125I radioactivity of the incorpo-
rated peptide are clearly local-
ized in or on granules, whereas
all other cellular structures/com-
partments are free of such label-
ing. Although not every mast cell
granule shows silver grains, it can
be assumed that most or all of
those within a cell had been in
contact with substance P. This ap-
parent discrepancy could be ex-
plained by the thickness of the
sections (only 50 nm), autoradio-
graphic geometrical factors, and
the exposure time. An example
of the possible variation regard-
ing radioactive signals from 125I-
all-D-SP in/on the same granules
sectioned at different levels is
given by comparing D and E. F
represents a cell from autoradiographic control specimens with unlabeled all-D-SP. Mast cells are imaged without heavy metal staining (to
prevent possible artifacts in the autoradiographs) using an integrated electron energy spectrometer of the ZEISS-transmission electron mi-
croscope EM 902 A (Carl Zeiss Jena GmbH). N, nucleus. Bars 5 1 mm.
(2)
where Ccell(z) is the peptide concentration in the cyto-
plasm, Ccomp(z) is the peptide concentration inside the
second compartment, and C(z) is the peptide concen-
tration of the extracellular medium.
Ccell(t) and also Ccomp were not available directly from
our measurements because the measured intracellular
fluorescence intensity represents an average intensity
over different compartments inside the cell. For this
reason, only a qualitative description is performed. The
lower values of the plateau of Icell(t) compared with the
values predicted by Eq. 1 with the mentioned different
k values can be explained if a decreased fluorescence
intensity of the peptide inside the second compartment
is assumed. In fact, an internal pH of #6 has been re-
ported for mast cell granules (Lagunoff and Rickard,
1983; Johnson et al., 1980) and the fluorescence inten-
sity of FLUOS-all-D-SP decreased by a factor of 2 when
the pH was lowered from 7.2 to 5.5.
To determine the location of SP inside the cell di-
rectly, 3H-labeled SP as well as 125I-labeled all-D-SP and
electron microscopic autoradiography were used. The
results of these investigations are shown in Fig. 4. From
Ccell t () k1
t0
t
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521 intact cells, 89% showed an intracellular labeling
from 125I-all-D-SP radioactivity, whereas 11% were not
labeled. Interestingly, silver grains resulting from incor-
porated peptide showed a clearly granule-related loca-
tion. 71% of silver grains were located in or on gran-
ules, 4% showed cytoplasmic location, and 25% could
not be classified unequivocally to either of these loca-
tions. The plasma membrane and nucleus, however,
were not labeled. Almost all sections containing a more
extended part of cytoplasm free from granules (see Fig.
4 A) showed no labeling in this cytosolic region. Some
isolated silver grains with irregular location (cytosolic
space, nucleus, intercellular area) as in Fig. 4 B have to
be considered as normal background of the photo-
graphic emulsion. These results suggest a location of
incorporated peptide preferentially inside or on gran-
ules. In favor of this suggestion is also the observation
that extracellular granules normally present in all prep-
arations in clusters showed similar labeling pattern and
intensity as granules inside the cells. Differences be-
tween cells incubated with 3H-SP or 125I-all-D-SP were
limited to the number of silver grains exclusively local-
ized in association with granules in each case. The lower
frequency of radioactive signals caused by 3H-SP was
possibly due to a loss of peptide by degradation. An ex-
tended incubation time (10Ð60 min) led only to a slight584 Peptide-induced Mast Cell Degranulation
increase in the degree of labeling of the granules. Also,
an intracellular location of SP could be detected auto-
radiographically using native mast cells (cryostat-sec-
tioned) at the light microscopic level (results not shown).
Preincubation of PtX-untreated mast cells with a low
nondegranulating dose of FLUOS-all-D-SP, followed by
washing and subsequent degranulation with compound
48/80, led to an average enhancement of fluorescence
by 109 6 24%, n 5 22, SEM. For the three cells shown
in Fig. 5, the fluorescence increase was 283%. These re-
sults are interpreted as follows. If translocated SP is ac-
cumulated in the secretory granules, then its fluores-
cence is quenched by a factor of 2 or more because of
the acidic granular pH. Upon degranulation, the fu-
sion pores open and the granular matrix will come into
contact with the extracellular medium. Due to expo-
sure of the granular matrix to this medium with higher
pH, an unquenching of intragranularly located SP
should occur. Therefore, in Fig. 5 the increase of fluo-
rescence is most likely due to unquenching of FLUOS-
all-D-SP-fluorescence in just releasing granules. The
cells exhibited a great variability in the fluorescence in-
crease, probably due to differences in the uptake and/
or differences in the granular pH resulting in different
degrees of quenching. The small increase of fluores-
cence in control cells without SP pretreatment (16 6
17%, n 5 17, SEM) might be the result of autofluores-
cence. The control cells with peptide pretreatment
showed a similar low fluorescence signal as the controls
without peptide pretreatment at the microscope set-
tings used. The low fluorescence of the pretreated cells
is obviously due to a large degree of quenching of accu-
mulated FLUOS-all-D-SP in these PtX-untreated cells.
The results shown demonstrate directly that extracellu-
larly applied SP translocates across the plasma mem-
brane and accumulates in the secretory granules.
Intracellular Action of SPÐPatch-Clamp Measurements 
To test if intracellularly applied peptide stimulates mast
cell degranulation, the patch-clamp technique in the
whole-cell mode was used. SP was directly applied via
the patch pipette and the time course of degranulation
was measured by determining the electrical capaci-
tance Cm of the cell membrane. For comparison, the
time course of capacitance increase was also deter-
mined for the nonhydrolyzable GTP analogue GTPgS,
known to stimulate mast cell degranulation when intra-
cellularly applied (Fernandez et al., 1984). 
A typical time course for the degranulation of a mast
cell dialyzed with 25 mM SP in low Ca21 buffering con-
ditions is shown in Fig. 6. The process was character-
Figure 5. Release of FLUOS-all-D-SP translocated into mast cells
stimulated with compound 48/80. Mast cells were treated with a
nondegranulating dose (1 mM) of FLUOS-all-D-SP for 1 min and
washed by centrifugation. Subsequently, the cells were stimulated
with 24 mg/ml compound 48/80 and fluorescence was monitored
15 s after beginning of degranulation. All images were obtained
with the same microscope settings. (top) Transmission images, (bot-
tom) fluorescence images. After stimulation of degranulation with
compound 48/80, the fluorescence of the three cells pretreated
with SP, shown, increased by 283% (FLUOS-all-D-SP 1 C48/80).
The average fluorescence increase was 109 6 24%, n 5 22, SEM.
This increase is most probably due to unquenching of accumu-
lated FLUOS-all-D-SP in just releasing granules. The small fluores-
cence (16 6 17%, n 5 17, SEM) observed after stimulation with
compound 48/80 in controls without SP pretreatment was attrib-
uted to autofluorescence. The fluorescence in control cells pre-
treated with FLUOS-all-D-SP was small (absolute intensity: 7), obvi-
ously due to a great degree of quenching of accumulated FLUOS-
all-D-SP in these cells.585 Lorenz et al.
ized by a time delay before the onset of degranulation
(for this cell, 250 s). The degranulation proceeded for
up to 500 s and led to a pronounced increase of Cm. Of
47 cells internally perfused with IS 1 containing SP at
different concentrations, 66% degranulated within 15Ð
20 min. In the degranulating cells, the membrane ca-
pacitance increased by a factor of 2.1 6 0.1, n 5 31. A
statistically significant dependence of the overall capac-
itance increase on peptide concentration was not de-
tected. It is noteworthy that intracellular concentrations
of SP as low as 5 (n 5 11) and 1 (n 5 3) mM stimulated
mast cell degranulation, whereas, at these concentra-
tions, no degranulation was found in mast cell suspen-
sions when the peptide was applied extracellularly. This
suggests that SP acts at an intracellular site.
Only 18% of control cells dialyzed internally with IS 1
in the absence of SP (4 of 22) showed spontaneous de-
granulation after 20 min, and in these four cells de-
granulation started after a long delay (10Ð15 min) and
was slow. 
When GTPgS was applied at similar concentrations,
degranulation occurred in 41 of 45 cells and the total
capacitance increase was 2.7 6 0.1-fold.
GDPbS applied together with SP through the patch-
pipette (1 mM GDPbS, 5 mM SP) inhibited exocytosis
in four of five cells tested. Likewise, pretreatment of
mast cells with PtX for 7Ð9 h led to inhibition of de-
granulation induced by 25 mM SP (n 5 4), whereas all
control cells incubated for the same time without PtX
degranulated (n 5 3). However, treatment with PtX for
shorter times (4 h) failed to give an adequate effect.
These results strongly suggest that intracellular applica-
tion of SP stimulates exocytosis via activation of GTP-
binding proteins. This is further supported by several
similarities between stimulation with GTPgS and SP. As
previously reported (Fernandez et al., 1987), the time
Figure 6. Mast cell degranulation induced by intracellular appli-
cation of SP. The time course of mast cell degranulation after dial-
ysis of SP through the patch pipette was measured as increase of
membrane capacitance (top). Series resistance (middle), and mem-
brane conductance (bottom). Pipette solution: IS 1 with 200 mM
EGTA and 25 mM SP. Arrow indicates time of patch rupture.
Figure 7. Time delay of mast cell degranulation in response to
intracellular application of SP (solid line) or GTPgS (dotted line)
through the patch pipette. Dependence on inverse concentration
(1/C) and effect of MgCl2 on the delay for SP. (d and j) SP with
7 mM MgCl2 (IS 1); (m) SP with 1 mM MgCl2 (IS 2); (h) GTPgS
with 7 mM MgCl2 (IS 1). In all cases, the pipette solution con-
tained 200 mM EGTA without Ca21, except j, where the free Ca21
concentration was 240 nM. (dotted line) Linear regression line for
GTPgS; (solid line) free hand line drawn for SP with 7 mM MgCl2.586 Peptide-induced Mast Cell Degranulation
delay depends linearly on the reciprocal GTPgS con-
centration (Fig. 7). Similarly, in SP-stimulated cells, the
time delay decreased with increasing peptide concen-
trations of SP (Fig. 7). In IS 1 containing 7 mM MgCl2,
the delay was longer than that observed for the G-pro-
tein activator GTPgS when applied at the same concen-
trations (Fig. 7). The shortest time delay obtained by
extrapolating the curves in Fig. 7 to high concentra-
tions was about 20 s for GTPgS, in agreement with pre-
vious data (Fernandez et al., 1987), and 50 s for SP.
The degranulation rate for SP was found to be 0.045 6
0.008 pF/s (1Ð25 mM, n 5 27) and 0.08 6 0.01 pF/s
(50 mM, n 5 4); for GTPgS, the degranulation rate in-
creased from 0.05 6 0.005 pF/s at 2.5Ð5 mM (n 5 25)
to 0.15 6 0.03 pF/s at 10Ð25 mM (n 5 16).
Reduction of the MgCl2 concentration in the intra-
cellular solution from 7 to 1 mM (IS 2) led to a de-
crease in the time delay of SP-induced exocytosis (Fig.
7). The degranulation rate increased approximately
twofold compared with that in IS 1. Under these con-
ditions, 15 of 25 cells degranulated with 10Ð50 mM SP
and none of the control cells dialyzed with IS 2 showed
any sign of degranulation (n 5 7). Omission of ATP in
the pipette abolished the SP-induced degranulation
(n 5 4).
To estimate the time required for SP to diffuse into
the cell, fluorescence measurements were done using
FLUOS-all-D-SP. For Rs in the range 9Ð20 MV, a diffu-
sion half time constant tD 5 18.2 6 4 s (n 5 4) was ob-
tained. Thus, diffusional exchange between pipette
and the cell interior is rapid.
As for GTPgS (Neher, 1988), the intracellular appli-
cation of SP caused transient rises followed by an ele-
vated level of [Ca21]i (Fig. 8). The onset of capacitance
increase occurred subsequent to the transient increase
of [Ca21]i. Controls without SP showed a resting level
of 140Ð200 nM of free Ca21.
Intracellular application of all-D-SP (25Ð200 mM)
also induced mast cell degranulation with a delay of
440 6 100 s, n 5 27 (IS 1 with 400 mM EGTA). The
time delay of the intracellular mast cell stimulation de-
pended on the Ca21-buffering conditions used, indicat-
ing a dependence on intracellular free Ca21 concentra-
tion. In weakly buffered conditions (200 mM EGTA),
when the intracellular Ca21 concentration was not un-
der the control of the pipette (Neher, 1988; Lindau
and Gomperts, 1991), a delay of 168 6 77 s (n 5 7) was
observed for 100 mM all-D-SP, whereas, in stronger
buffering conditions (1,200 mM EGTA), no degranula-
tion occurred.
In addition to the SP derivatives mentioned above,
we tested SP(1-4)dodecylamide, which caused mast cell
degranulation with a 10-fold lower ED25 compared with
SP when applied extracellularly (Repke et al., 1987). At
a concentration of 1 mM, this analogue showed an in-
tracellular stimulation of mast cell degranulation with a
time delay of 303 6 85 s (n 5 7) (IS 1 with 200 mM
EGTA).
RT-PCR
The PCR product of the NK1 receptor in the pituitary
samples, used as positive control for NK1 receptor
mRNA, had the predicted size of 380 bp (Fig. 9 A). Fur-
thermore, the specificity was confirmed by hybridiza-
tion with an NK1 receptor-specific DIG-labeled oligonu-
cleotide. RNA isolated from mast cells did not give an
adequate signal in the RT-PCR reaction (Fig. 9 A). 
The quality of the RNA preparation of mast cells was
checked in another RT-PCR with primers specific for
GAPDH. The PCR products showed an adequate signal
in both mast and pituitary cells (Fig. 9 B).
discussion
The mechanism of peptide-induced mast cell activation
has been unclear, although a variety of studies concern-
ing this problem have been undertaken. It had been
Figure 8. Intracellular calcium transients in mast cells induced
by intracellular application of SP. Simultaneously measured time
courses of intracellular free Ca21 concentration (solid line) and ca-
pacitance (dotted line) with (A) and without (B) intracellular appli-
cation of SP through the patch pipette. Pipette solution: IS 2 with
or without 10 mM SP, and 100 mM FURA-2 and 100 mM EGTA.
The arrow indicates the time of patch rupture.587 Lorenz et al.
suggested (Mousli et al., 1990b) that the peptides inter-
act directly with heterotrimeric G proteins, thereby
mimicking the receptor. Such a mechanism would re-
quire a deep insertion of peptides into the membrane
and/or their translocation into the cytoplasm of mast
cells. According to this model, intracellular application
of SP should induce mast cell exocytosis. The aim of
the present investigation was to answer the questions:
(a) Do SP-specific receptors exist in the plasma mem-
brane of rat peritoneal mast cells? (b) Can extracellu-
larly applied SP be translocated into mast cells? and (c)
Is intracellularly applied SP able to induce mast cell de-
granulation?
Using RT-PCR (Fig. 9, A and B), no SP receptor-spe-
cific mRNA was detected in mast cells, whereas mRNA
for GAPDH (a ÒhousekeepingÓ gene expressed in all
cells) used as quality control for the DNA preparation
was demonstrable in these cells; moreover, in rat pitu-
itary cells, mRNAs for both SP receptor and GAPDH
were found. These results support the view of a SP-
receptorÐindependent action of SP on mast cells.
For the investigation of the uptake of SP into mast
cells by CLSM, the fluorescence-labeled SP derivatives
FLUOS-SP and FLUOS-all-D-SP were synthesized. These
analogues showed pronounced histamine releasing ac-
tivity, but the doseÐresponse curve of the all-D ana-
logues was shifted to higher concentrations compared
with SP. The all-D-SP was used because of its high enzy-
matic stability. Therefore, an uptake of peptide degra-
dation products into mast cells during translocation ex-
periments could be excluded.
The pertussis toxin treatment, performed to prevent
artifacts associated with degranulation, did not disturb
the integrity of the plasma membrane as revealed from
electron microscopic observations and from trypan blue
staining. In addition, the nonÐmembrane-penetrating
dyes carboxyfluorescein and BSA-rhodamine were not
translocated into PtX-treated mast cells (Wiesner et al.,
manuscript in preparation).
The results obtained by CLSM directly show translo-
cation of SP peptides into PtX-treated cells (Figs. 1Ð3).
The kinetic experiments (Fig. 2, B and C) indicated
that the translocation process was rapid, occurring
within a few seconds. After the maximum was reached,
the fluorescence intensity decayed to a greater extent
inside the cell than in the outside medium (Fig. 2 C),
indicating that an additional decay process is superim-
posed on the uptake process. Photobleaching of FLUOS
peptides by the laser was precluded by control experi-
ments and the use of all-D analogues of SP eliminated
any possible loss of peptide due to peptide degrada-
tion. The results of modeling the time course of uptake
of SP using diffusion models led to the proposal that a
second translocation process should take place such as
an uptake into mast cell granules, where the fluores-
cence of the peptide is quenched. The results of CLSM
experiments are directly supported by the electron mi-
croscopic autoradiography (Fig. 4) and by experiments
shown in Fig. 5. Electron microscopic autoradiography
with 125I-all-D SP and 3H-SP demonstrated a location of
SP preferentially on or inside the granules (Fig. 4).
However, SP was not found in the nucleus, the cyto-
plasm, or on the plasma membrane. The latter finding
is not surprising because SP bound to the plasma mem-
brane was removed by washing. Furthermore, a radio-
active staining on the cytosolic side of the membrane
due to the proposed interaction of the Òreceptor-mim-
ickingÓ SP with membrane-bound Gi/o proteins is not
likely because such interactions are blocked by PtX
treatment. The autoradiographic resolution does not
Figure 9. Analysis of RT-PCR
products obtained by the use of
SP-receptorÐspecific primers (A),
and by use of GAPDH-specific
primers (B). (A) Lanes 1 and 5,
positive control (rat pituitary, 1
mg total RNA); lanes 2 and 6,
mast cells (0.5 mg total RNA);
lanes  3 and 7, mast cells (1 mg to-
tal RNA), lanes 4 and 8, DNA
marker, l/Hind III. (B) Lane 1,
DNA marker, l/Hind III; lane 2,
rat pituitary (0.5 mg total RNA);
lane 3 mast cells (0.5 mg total
RNA); lane 4 negative control
(RNA without reverse transcrip-
tion). Lanes 1Ð4, 3% agarose gel,
ethidium bromide stained; lanes
5Ð8, Southern blot hybridized
with SP receptor digoxigenin-
labeled oligonucleotide. 588 Peptide-induced Mast Cell Degranulation
allow a conclusion as to whether SP is located on the
granule membrane and/or within the granules. How-
ever, SP is most likely located at least partly inside the
granules, as indicated by the fact that an increase of flu-
orescence intensity occurred when mast cells, pre-
loaded with a nondegranulating dose of the fluores-
cent peptide, were stimulated by compound 48/80.
The degranulation results in an exposure of the granu-
lar matrix to the extracellular medium with higher pH
and, therefore, in a rise of fluorescence of intragranu-
larly localized peptide (Fig. 5).
Secretory granules of mast cells contain a heparin
proteoglycan matrix (Sayama et al., 1987), which is
negatively charged at the granular acidic pH. Recently, it
was demonstrated (Parpura and Fernandez, 1996) that
this matrix behaves as an ion-exchange resin. On the
other hand, strong binding of cationic peptides to nega-
tively charged ion exchangers possessing hydrophobic
groups (e.g., Dowex) has been shown (Berger et al.,
1982). This may explain binding of positively charged SP
to the granule matrix. The independence of peptide up-
take on concentration and the finding that the uptake is
not saturable in the concentration range used (Fig. 3) is
in agreement with the accumulation and binding of SP
inside the granules. However, binding of SP to other
proteins on the granular membrane or inside the gran-
ule cannot be excluded and remains to be elucidated.
The mechanism by which the transport of cationic
peptides into mast cells takes place is unknown. The
short time of translocation suggests mechanisms inde-
pendent of classical endocytosis, which typically has
shown half-lives .10 min. Nonspecific diffusion of SP
peptides due to membrane damage could be excluded
since cells showed trypan blue exclusion for at least
5 min after the translocation experiments. The absence
of a saturable uptake (Fig. 3) and the fact that metabol-
ically inhibited cells have the same uptake suggest that
active transporters are not involved in the translocation
process. This is in agreement with recently reported
studies of the energy-independent translocation of pep-
tides derived from the third helix of Antennapedia ho-
meodomain into neuronal cells (Derossi et al., 1994).
Cellular uptake of peptides derived from HIV-1 Tat
protein (Vivs et al., 1997) and from the hydrophobic
region of various protein signal sequences (Lin et al.,
1995; Lui et al., 1996) and of model peptides (Oehlke
et al., 1996, 1997) was previously demonstrated. Inter-
estingly, large transmembrane movements of segments
of the protein toxin colicin and inserted foreign epitopes
across planar lipid bilayer membranes associated with
channel opening and closing were recently observed
(Qiu et al., 1996; Jakes et al., 1998). The authors sug-
gest that a small part of colicin itself acts as a nonspe-
cific translocator. Furthermore, it was found that pep-
tides such as mitochondrial presequences (Maduke
and Roise, 1993) or magainin 2 and mastoparan (Mat-
zusaki et al., 1995, 1996) are imported into liposomes.
These peptides are relatively large and it was suggested
(Matzusaki et al., 1995) that they can adopt an amphi-
pathic helical, membrane-spanning conformation, build-
ing a short-lived pore (z40 ms lifetime). The pore for-
mation is thought to be coupled with peptide trans-
location. However, SP is too short to adopt such a
membrane-spanning conformation; thus, another mech-
anism must be responsible for SP peptide translocation.
One mechanism of uptake of SP without entering the
cytoplasm at all might be diffusion of the peptide into
the secretory granules through flickering fusion pores
(Alvarez de Toledo et al., 1993). This is not likely be-
cause PtX inhibited degranulation when SP uptake was
measured. In addition, we also observed an uptake into
aortic endothelial and HEK293 cells (Oehlke et al.,
1997; D. Lorenz and B. Wiesner, unpublished data).
The patch-clamp measurements indicated that intra-
cellularly applied peptide activates mast cell degranula-
tion (Figs. 6 and 8). However, SP showed a longer time
delay compared with the G-protein activator GTPgS
(Fig. 7), and the degranulation amplitude was some-
what reduced. The diffusion of the peptide from the
patch pipette into the cell seems not to be responsible
for the observed time delay because diffusional time
measurements demonstrated a fast diffusional ex-
change of peptide between pipette and the cell interior.
Nonspecific membrane-perturbing effects of the pep-
tide leading to degranulation are unlikely, because in
the absence of ATP the intracellular stimulation by the
peptide was abolished. The fact that GDPbS and per-
tussis toxin treatment inhibited the SP-induced intra-
cellular activation points to the involvement of hetero-
trimeric G proteins. The observation that reduction of
the free Mg21 concentration in the patch pipette from
7 to 1 mM decreased the time delay (Fig. 7) further
supports G protein involvement. It has been shown that
the activation of heterotrimeric Gi/o proteins by cat-
ionic peptides is reduced at high millimolar Mg21 con-
centrations (Higashijima et al., 1990). However, other
Mg21-dependent cellular events might be involved. SP
induced fast transient rises in [Ca21]i (Fig. 8), presum-
ably as a result of Ca21 release from internal stores due
to G proteinÐmediated activation of PLC by intracellu-
larly applied SP. The elevated level of [Ca21]i following
the transients was similar to those observed when SP or
compound 48/80 was applied extracellularly to mast
cells (Penner et al., 1988; Matthews et al., 1989) and
has been shown to be the result of activation of Ca21-
releaseÐactivated Ca21 channels and of nonspecific cat-
ion channels (Hoth and Penner, 1992; Fasalato et al.,
1993; Kuno et al., 1989). 
The patch-clamp results show that intracellularly ap-
plied SP stimulates mast cell degranulation, suggesting589 Lorenz et al.
a direct activation of heterotrimeric PtX-sensitive G
proteins linked to PLC activation and release of Ca21
from internal stores. Whether the recently found Gi3,
thought to act downstream of PLC to trigger exocytosis
(Aridor et al., 1990, 1993), and/or other G proteins are
activated directly by intracellularly applied SP cannot
be ascertained from the presented data. The inhibition
of exocytosis found when [Ca21]i was clamped to low
values by EGTA suggests that a certain level of free Ca21
is necessary for the SP-induced exocytosis. Obviously, as
reported previously (Lillie and Gomperts, 1993), Ca21
modulates degranulation by enhancing the sensitivity
for GTP of the G protein downstream of PLC. Also, the
possible additional involvement of other proteins can-
not be excluded. Activation of the nucleoside diphos-
phate kinase in HeLa cells by the cationic peptide mas-
toparan has been reported (Klinker et al., 1994), result-
ing in transphosphorylation of GDP to GTP in the
presence of ATP, and thereby maintaining a pool of
available GTP. Likewise, an inhibition of GTPase-acti-
vating proteins cannot be ruled out.
That a cationic peptide can stimulate mast cell de-
granulation intracellularly was observed also by Ober-
hauser et al. (1992). Synthetic peptides, corresponding
to the putative effector domain of the small G protein
rab 3, were reported to stimulate exocytosis in patch-
clamped mast cells (Oberhauser et al., 1992). It was
suggested that rab 3 peptides act directly on the effec-
tor protein, which is part of the protein macrocomplex
of the exocytotic fusion pore. On the other hand, rab
3-like peptides have been shown to stimulate exocytosis
via a PtX-sensitive G protein when applied extracellu-
larly (Law et al., 1993). They were able to induce Ca21
transients and did not stimulate exocytosis when cells
were treated with PtX. Interestingly, these peptides
show similarities in their structure with mastoparan,
known to stimulate purified Gi proteins and mast cell
exocytosis. Induction of exocytosis by mastoparan has
also been demonstrated in permeabilized AtT 20 cells
(McFerran and Guild, 1995). In permeabilized chro-
maffin cells, mastoparan showed inhibitory as well as
stimulatory effects on exocytosis, depending on the ab-
sence or presence of MgATP and Mg21 (Vitale et al.,
1996).
In summary, our study demonstrates that SP is trans-
located into mast cells in an energy- and SP-receptorÐ
independent fashion. Inside the cell, the peptide was
found to be exclusively in or on the mast cell granules.
Intracellularly applied peptide induced exocytosis, which
was blocked by GDPbS and PtX treatment, suggesting
the involvement of heterotrimeric G proteins. Simulta-
neous measurements of degranulation and of the intra-
cellular free Ca21 concentration demonstrated directly
that the heterotrimeric G protein linked to PLC activa-
tion was stimulated by intracellularly applied SP. How-
ever, the involvement of other proteins cannot be ex-
cluded and remains to be elucidated. Thus, SP-induced
activation of isolated mast cells seems to be a receptor-
independent process, initiated by binding of SP to neg-
atively charged binding sites on the plasma membrane
and followed by a translocation of peptide into the
mast cell, where it stimulates G proteins directly.
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